{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:9037"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:9037","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"The characterisation of neutrophil function in patients undergoing colorectal cancer resection and the impact of HMG-COA reductase inhibitors on host inflammation","abstract":"Cancer-associated inflammation, both in the systemic circulation and in the tumour microenvironment, is widely recognised to influence disease progression and survival. Surgical resection is fundamental in achieving cure in patients with colorectal cancer. The generation and maintenance of a systemic inflammatory response, with subsequent compromise of the anti-tumour immune response, has been associated with poor outcome. Neutrophils may facilitate metastatic progression in the context of systemic inflammation and therefore implementing a therapeutic strategy in the peri-operative period to reduce the systemic inflammation associated with surgery may be beneficial, particularly therapeutic strategies aimed at modifying tumour-neutrophil interactions. HMG-CoA Reductase Inhibitors (statins) were developed as lipid-lowering agents. In addition, they have been implicated in the modulation of the immune system and have demonstrable anti-inflammatory effects. It has been proposed that they could be utilised in the peri-operative period to modulate the systemic inflammatory response and to preserve the anti-tumour immune competency of the host. This study was conducted to serially characterise neutrophil function in patients undergoing colorectal cancer resection over the peri-operative period and to explore the impact of HMG-CoA Reductase Inhibitors on neutrophil function.","abstract_html":"Cancer-associated inflammation, both in the systemic circulation and in the tumour microenvironment, is widely recognised to influence disease progression and survival. Surgical resection is fundamental in achieving cure in patients with colorectal cancer. The generation and maintenance of a systemic inflammatory response, with subsequent compromise of the anti-tumour immune response, has been associated with poor outcome. Neutrophils may facilitate metastatic progression in the context of systemic inflammation and therefore implementing a therapeutic strategy in the peri-operative period to reduce the systemic inflammation associated with surgery may be beneficial, particularly therapeutic strategies aimed at modifying tumour-neutrophil interactions. HMG-CoA Reductase Inhibitors (statins) were developed as lipid-lowering agents. In addition, they have been implicated in the modulation of the immune system and have demonstrable anti-inflammatory effects. It has been proposed that they could be utilised in the peri-operative period to modulate the systemic inflammatory response and to preserve the anti-tumour immune competency of the host. This study was conducted to serially characterise neutrophil function in patients undergoing colorectal cancer resection over the peri-operative period and to explore the impact of HMG-CoA Reductase Inhibitors on neutrophil function.","abstract_has_math":false,"creators":["Richardson, Jonathan James Robert"],"institution":"University of Birmingham","degree_name":"d_m_d","degree_level":"d_m_d","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2019,"date_issued":"2019-07","date_published":"2019-07","updated_at":"2026-11-19T09:30:27Z","subjects":["RC0254 Neoplasms. Tumors. Oncology (including Cancer)"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/9037/1/Richardson2019MD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A9037","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Richardson, Jonathan James Robert"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2019-07-01"]},{"key":"dc:date.issued","label":"Date","values":["2019-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Inflammation and Ageing"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/9037/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_m_d"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_m_d"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["RC0254 Neoplasms. Tumors. Oncology (including Cancer)"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/9037/1/Richardson2019MD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Cancer-associated inflammation, both in the systemic circulation and in the tumour microenvironment, is widely recognised to influence disease progression and survival. Surgical resection is fundamental in achieving cure in patients with colorectal cancer. The generation and maintenance of a systemic inflammatory response, with subsequent compromise of the anti-tumour immune response, has been associated with poor outcome. Neutrophils may facilitate metastatic progression in the context of systemic inflammation and therefore implementing a therapeutic strategy in the peri-operative period to reduce the systemic inflammation associated with surgery may be beneficial, particularly therapeutic strategies aimed at modifying tumour-neutrophil interactions. HMG-CoA Reductase Inhibitors (statins) were developed as lipid-lowering agents. In addition, they have been implicated in the modulation of the immune system and have demonstrable anti-inflammatory effects. It has been proposed that they could be utilised in the peri-operative period to modulate the systemic inflammatory response and to preserve the anti-tumour immune competency of the host. This study was conducted to serially characterise neutrophil function in patients undergoing colorectal cancer resection over the peri-operative period and to explore the impact of HMG-CoA Reductase Inhibitors on neutrophil function."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["The characterisation of neutrophil function in patients undergoing colorectal cancer resection and the impact of HMG-COA reductase inhibitors on host inflammation"]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Richardson, Jonathan James Robert"],"dc:date":["2019-07-01"],"dc:date.issued":["2019-07"],"dc:description.abstract":["Cancer-associated inflammation, both in the systemic circulation and in the tumour microenvironment, is widely recognised to influence disease progression and survival. Surgical resection is fundamental in achieving cure in patients with colorectal cancer. The generation and maintenance of a systemic inflammatory response, with subsequent compromise of the anti-tumour immune response, has been associated with poor outcome. Neutrophils may facilitate metastatic progression in the context of systemic inflammation and therefore implementing a therapeutic strategy in the peri-operative period to reduce the systemic inflammation associated with surgery may be beneficial, particularly therapeutic strategies aimed at modifying tumour-neutrophil interactions. HMG-CoA Reductase Inhibitors (statins) were developed as lipid-lowering agents. In addition, they have been implicated in the modulation of the immune system and have demonstrable anti-inflammatory effects. It has been proposed that they could be utilised in the peri-operative period to modulate the systemic inflammatory response and to preserve the anti-tumour immune competency of the host. This study was conducted to serially characterise neutrophil function in patients undergoing colorectal cancer resection over the peri-operative period and to explore the impact of HMG-CoA Reductase Inhibitors on neutrophil function."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/9037/1/Richardson2019MD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Inflammation and Ageing"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/9037/"],"dc:subject":["RC0254 Neoplasms. Tumors. Oncology (including Cancer)"],"dcterms:accessrights":["public"],"dc:title":["The characterisation of neutrophil function in patients undergoing colorectal cancer resection and the impact of HMG-COA reductase inhibitors on host inflammation"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_m_d"],"dc:type.qualificationname":["d_m_d"]},"updated_at":"2026-11-19T09:30:27Z"}